GBA1 and Parkinson disease: Recently, Lerche et al. (68) combined the analysis of multiple metabolites in PD patients with and without GBA mutations and showed specific differential metabolite profiles regarding α-synuclein, glucocerebrosidase activity, and glucosylceramides between the two groups (40).